Tom Corbett

1.2k total citations
16 papers, 308 citations indexed

About

Tom Corbett is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Tom Corbett has authored 16 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Rheumatology. Recurrent topics in Tom Corbett's work include Prostate Cancer Treatment and Research (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Soft tissue tumor case studies (4 papers). Tom Corbett is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Soft tissue tumor case studies (4 papers). Tom Corbett collaborates with scholars based in Canada, United States and Australia. Tom Corbett's co-authors include Michelle Ghert, Forough Farrokhyar, Malti Patel, Himu Lukka, Joel Werier, Abha A. Gupta, Xiaomei Yao, Kathleen Quinn, Thomas J. Wood and Rita A. Kandel and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Tom Corbett

15 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Corbett Canada 11 232 141 105 48 47 16 308
Marc Bienz Canada 10 184 0.8× 65 0.5× 84 0.8× 14 0.3× 17 0.4× 23 284
Roland Umbach Germany 6 95 0.4× 44 0.3× 122 1.2× 25 0.5× 70 1.5× 7 274
G. Saibene Italy 6 84 0.4× 366 2.6× 43 0.4× 25 0.5× 199 4.2× 10 452
Greet Esselens Belgium 6 41 0.2× 44 0.3× 287 2.7× 60 1.3× 27 0.6× 7 428
J. Mirra United States 6 266 1.1× 172 1.2× 83 0.8× 33 0.7× 63 1.3× 8 366
M.J. Tennapel United States 12 104 0.4× 86 0.6× 28 0.3× 21 0.4× 6 0.1× 41 425
Sheila A. Conway United States 9 205 0.9× 107 0.8× 139 1.3× 46 1.0× 8 0.2× 33 319
Steen Bærentzen Denmark 11 236 1.0× 134 1.0× 94 0.9× 49 1.0× 3 0.1× 23 328
Michael J. Allen Canada 11 64 0.3× 104 0.7× 39 0.4× 15 0.3× 9 0.2× 36 282
Nicole D. Riddle United States 11 126 0.5× 80 0.6× 138 1.3× 30 0.6× 4 0.1× 33 295

Countries citing papers authored by Tom Corbett

Since Specialization
Citations

This map shows the geographic impact of Tom Corbett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Corbett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Corbett more than expected).

Fields of papers citing papers by Tom Corbett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Corbett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Corbett. The network helps show where Tom Corbett may publish in the future.

Co-authorship network of co-authors of Tom Corbett

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Corbett. A scholar is included among the top collaborators of Tom Corbett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Corbett. Tom Corbett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Dayes, Ian S., Charles Catton, Amy Liu, et al.. (2025). Patient-reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer. European Urology Oncology. 9(1). 26–36. 1 indexed citations
3.
Zeng, Yiye, Tom Corbett, Donna Manca, et al.. (2014). You are how you recruit: a cohort and randomized controlled trial of recruitment strategies. BMC Medical Research Methodology. 14(1). 111–111. 22 indexed citations
4.
Yao, Xiaomei, Tom Corbett, Abha A. Gupta, et al.. (2014). A Systematic Review of Active Treatment Options in Patients with Desmoid Tumours. Current Oncology. 21(4). 613–629. 24 indexed citations
5.
Ghert, Michelle, Xiaomei Yao, Tom Corbett, et al.. (2014). Treatment and Follow-Up Strategies in Desmoid Tumours: A Practice Guideline. Current Oncology. 21(4). 642–649. 16 indexed citations
6.
Wood, Thomas J., et al.. (2013). Local control of extra-abdominal desmoid tumors: systematic review and meta-analysis. Rare Tumors. 5(1). 2–2. 14 indexed citations
7.
Wood, Thomas J., et al.. (2013). Local control of extra-abdominal desmoid tumors: systematic review and meta-analysis. Rare Tumors. 5(1). 5–10. 22 indexed citations
8.
Choo, Richard, Himu Lukka, Patrick Cheung, et al.. (2012). Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1239–1245. 42 indexed citations
9.
Hanisch, Laura J., Charlene Bryan, J. James, et al.. (2012). Impact of sildenafil on marital and sexual adjustment in patients and their wives after radiotherapy and short-term androgen suppression for prostate cancer. Supportive Care in Cancer. 20(11). 2845–2850. 3 indexed citations
10.
Al‐Shamsi, Humaid O., Arthur Lau, Abdulaziz Alamri, et al.. (2012). The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer. Journal of Oncology. 2012. 1–7. 14 indexed citations
11.
Crook, Juanita, Chris J. O’Callaghan, Kevin Ding, et al.. (2011). A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013).. Journal of Clinical Oncology. 29(15_suppl). 4514–4514. 33 indexed citations
12.
Farrokhyar, Forough, et al.. (2010). A Systematic Review and Meta-Analysis of Oncologic Outcomes of Pre- Versus Postoperative Radiation in Localized Resectable Soft-Tissue Sarcoma. Annals of Surgical Oncology. 17(5). 1367–1374. 73 indexed citations
13.
Tsakiridis, Theodoros, Jean‐Claude Cutz, Gurmit Singh, et al.. (2008). Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy. Journal of Thoracic Oncology. 3(7). 716–722. 14 indexed citations
14.
Sur, Ranjan, Bernard Donde, Serge Puksa, et al.. (2008). Results of a Prospective Study on Brachytherapy in Lung Cancer in Combination with other Modalities. International Journal of Radiation Oncology*Biology*Physics. 72(1). S440–S441. 1 indexed citations
15.
Duncan, Graeme, Tom Corbett, Himu Lukka, Padraig Warde, & Tom Pickles. (2006). GU radiation oncologists consensus on bone loss from androgen deprivation.. PubMed. 13(1). 2962–6. 18 indexed citations
16.
Epstein, Joel B., et al.. (1994). Surgical periodontal treatment in the radiotherapy‐treated head and neck cancer patient. Special Care in Dentistry. 14(5). 182–193. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026